|
The Alpha Biologics facility has been designed in compliance
with both FDA and EMEA guidelines. The design has been favourably
reviewed by the Centre of Drug Evaluation and Research at
FDA, with advice from CDER incorporated into the final design.
We fully expect and welcome facility audits from both regulatory
authorities within the first two years of operation of the
facility.
|
